机译:胸腺外产生的调节性T细胞控制粘膜T_H2炎症
Howard Hughes Medical Institute and Immunology Program, Sloan Kettering Institute, New York, New York 10021, USA,Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York 10065, USA;
Howard Hughes Medical Institute and Immunology Program, Sloan Kettering Institute, New York, New York 10021, USA;
Division of Immunology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA;
Department of Comparative Medicine, and Histology and Imaging Core, School of Medicine, University of Washington, Seattle, Washington 98195, USA;
Howard Hughes Medical Institute and Immunology Program, Sloan Kettering Institute, New York, New York 10021, USA,Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo 160-8582, Japan;
Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California 92037, USA;
Division of Immunology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA;
Howard Hughes Medical Institute and Immunology Program, Sloan Kettering Institute, New York, New York 10021, USA;
机译:脱近产生的调节性T细胞为肠道居住细菌建立了一个Niche,影响生理代谢物平衡
机译:调节性T细胞抑制全身和粘膜免疫激活,以控制肠道炎症。
机译:调节性T细胞抑制程序选择转录因子Irf4来控制T_h2反应
机译:粘膜免疫系统的反调节与粘膜炎症的机制
机译:诱导型T细胞共刺激剂稳定调节性T细胞表型并控制宿主微生物蛋白相互作用,以减少对肠炎症的敏感性
机译:Extrathymically产生调节性T细胞控制粘膜炎Th2的
机译:细胞产生的调节T细胞控制粘膜Th2炎症